This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Venlafaxine XR and Chronic Pelvic Pain Syndrome

Jordan F. Karp, MD

Published: June 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Venlafaxine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI), has been shown to have analgesic effects in neuropathic1-3 and postsurgical pain4 and in pain and uncomfortable physical symptoms associated with premenstrual dysphoric disorder.5 This agent has also been reported to both prevent and resolve hyperalgesia in rats with experimentally produced painful neuropathic lesions.6

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: